Overview of the FDA Philippines Medical Device Regulatory Framework
An overview of the Philippine FDA's Center for Device Regulation, Radiation Health, and Research (CDRRHR) and its role in licensing and product registration.
Overview
Summary of this regulator or jurisdiction and how it relates to market access.
Food and Drug Administration (FDA) Philippines - CDRRHR
The Center for Device Regulation, Radiation Health, and Research (CDRRHR) is the specialized branch of the Philippine FDA responsible for the regulation of medical devices, ensuring they meet national standards for safety, quality, and efficacy.
1. Regulatory Role
Under Republic Act No. 9711, the FDA mandates that all medical device establishments must obtain a License to Operate (LTO) and register their products before they can be legally distributed in the country.
2. Licensing of Establishments (LTO)
The provided eServices portal facilitates the application for the LTO. This license is required for:
- Manufacturers
- Traders
- Distributors (Importers, Exporters, and Wholesalers)
3. Product Classification and Registration
In alignment with ASEAN Harmonized Templates, the Philippines classifies devices based on risk:
- Class A (Low Risk): Requires a Certificate of Medical Device Notification (CMDN).
- Class B (Low-Moderate Risk): Requires a Certificate of Medical Device Registration (CMDR).
- Class C (Moderate-High Risk): Requires a CMDR.
- Class D (High Risk): Requires a CMDR.
4. Digital Transformation (eServices)
The FDA has transitioned to an online platform for LTO applications to streamline the process, reduce manual paperwork, and enhance transparency in the regulatory pipeline.
Articles & guides
Insight articles mapped to this region on ElendiLabs.